Apellis Pharmaceuticals (APLS) Q4 2024 Earnings

Nov 5Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.73
-0.59
-0.44
-0.29

Details

Expected EPS
-0.294942
Actual EPS
-0.46
Surprise EPS
-0.17
Surprise Percent
-55.96%

Description

⁨Apellis Pharmaceuticals⁩ (⁦APLS⁩) has reported earnings of ⁦-0.46⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts